Zobrazeno 1 - 6
of 6
pro vyhledávání: '"N. M. Khomeriki"'
Autor:
N. M. Khomeriki, I. A. Morozov
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 112-119 (2017)
The article provides historic development of ideas about the protective mucous barrier in the stomach, a modern vision of the cytoprotection in the stomach is provided, and possibilities of pharmacologic cytorpotective drugs are described. Cytoprotec
Externí odkaz:
https://doaj.org/article/50d518bdd0bd4f1b97e68b953233c2b6
Autor:
V. B. Grinevich, L. B. Lazebnik, Yu. A. Kravchuk, V. G. Radchenko, E. I. Tkachenko, A. M. Pershko, P. V. Seliverstov, C. P. Salikova, K. V. Zhdanov, K. V. Kozlov, V. V. Makienko, I. V. Potapova, E. S. Ivanyuk, D. V. Egorov, E. I. Sas, M. D. Korzheva, N. M. Kozlova, A. K. Ratnikova, V. A. Ratnikov, S. I. Sitkin, L. Z. Bolieva, C. V. Turkina, D. I. Abdulganieva, T. V. Ermolova, S. A. Kozhevnikova, L. V. Tarasova, R. G. Myazin, N. M. Khomeriki, T. L. Pilat, L. P. Kuzmina, R. A. Khanferyan, V. P. Novikova, A. V. Polunina, A. I. Khavkin
Publikováno v:
Experimental and Clinical Gastroenterology. :4-68
Summary Post- COVID syndrome refers to the long-term consequences of a new coronavirus infection COVID-19, which includes a set of symptoms that develop or persist after COVID-19. Symptoms of gastrointestinal disorders in post- COVID syndrome, due to
Autor:
N. M. Khomeriki
Publikováno v:
Experimental and Clinical Gastroenterology. :152-156
It has been proven that the virus of the new coronavirus infection SARS-CoV-2 enters the body not only through the respiratory tract, but also through the cells of the gastrointestinal tract, on the surface of which receptors (or entry gates) for the
Autor:
L B, Lazebnik, S G, Khomeriki, I A, Morozov, V I, Kas'ianenko, L A, Zvenigorodskaia, N M, Khomeriki, L S, Goncharenko
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (4)
Publikováno v:
Klinicheskaia meditsina. 77(11)
Autor:
I V Maev, Yu A Kucheravy, V V Tsukanov, E Yu Eremnia, D N Andreev, S R Abdulhakov, V A Akhmedov, S S Batskov, A V Vasyutin, E S V’yuchnova, D N Ivanchenko, E V Luzina, O V Krapivnaya, E V Onuchina, M F Osipenko, V I Simanenkov, Yu L Tonkih, N M Khomeriki, A E Shklyaev, A V Akimov, K A Sokolov
Publikováno v:
Терапевтический архив, Vol 90, Iss 8, Pp 40-47 (2018)
Aim: to assess the effectiveness of mebeverine 200 mg BID in patients with post-cholecystectomy gastrointestinal spasm not requiring surgical treatment. Materials and methods. 218 patients were included in 16 clinical centers in 14 cities in Russia.
Externí odkaz:
https://doaj.org/article/44709d1c302f481cac60560922ee77a7